BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 26163426)

  • 1. Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome.
    Bernabéu-Herrero ME; Jiménez-Alcázar M; Anter J; Pinto S; Sánchez Chinchilla D; Garrido S; López-Trascasa M; Rodríguez de Córdoba S; Sánchez-Corral P
    Mol Immunol; 2015 Oct; 67(2 Pt B):276-86. PubMed ID: 26163426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele
    Pouw RB; Gómez Delgado I; López Lera A; Rodríguez de Córdoba S; Wouters D; Kuijpers TW; Sánchez-Corral P
    Front Immunol; 2018; 9():848. PubMed ID: 29740447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor H Competitor Generated by Gene Conversion Events Associates with Atypical Hemolytic Uremic Syndrome.
    Goicoechea de Jorge E; Tortajada A; García SP; Gastoldi S; Merinero HM; García-Fernández J; Arjona E; Cao M; Remuzzi G; Noris M; Rodríguez de Córdoba S
    J Am Soc Nephrol; 2018 Jan; 29(1):240-249. PubMed ID: 28993505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical hemolytic uremic syndrome associated with complement factor H autoantibodies and CFHR1/CFHR3 deficiency.
    Lee BH; Kwak SH; Shin JI; Lee SH; Choi HJ; Kang HG; Ha IS; Lee JS; Dragon-Durey MA; Choi Y; Cheong HI
    Pediatr Res; 2009 Sep; 66(3):336-40. PubMed ID: 19531976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C; Martínez-Barricarte R; López-Trascasa M; de Córdoba SR; Sánchez-Corral P
    Blood; 2009 Nov; 114(19):4261-71. PubMed ID: 19745068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: A family of atypical hemolytic uremic syndrome involving a
    Tasaki Y; Tsujimoto H; Yokoyama T; Sugimoto N; Kitajima S; Fujii H; Hidaka Y; Kato N; Maruyama S; Inoue N; Wada T
    Front Immunol; 2024; 15():1360855. PubMed ID: 38524137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome.
    Zipfel PF; Edey M; Heinen S; Józsi M; Richter H; Misselwitz J; Hoppe B; Routledge D; Strain L; Hughes AE; Goodship JA; Licht C; Goodship TH; Skerka C
    PLoS Genet; 2007 Mar; 3(3):e41. PubMed ID: 17367211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare Functional Variants in Complement Genes and Anti-FH Autoantibodies-Associated aHUS.
    Valoti E; Alberti M; Iatropoulos P; Piras R; Mele C; Breno M; Cremaschi A; Bresin E; Donadelli R; Alizzi S; Amoroso A; Benigni A; Remuzzi G; Noris M
    Front Immunol; 2019; 10():853. PubMed ID: 31118930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
    Grenda R; Jarmużek W; Rubik J; Prokurat S; Miklaszewska M; Drozdz D; Zachwieja K; Ardissino G; Hofer J
    Pediatr Transplant; 2015 Sep; 19(6):E130-4. PubMed ID: 26087050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Genetic Variants and FH Desialylation in
    Gómez Delgado I; Corvillo F; Nozal P; Arjona E; Madrid Á; Melgosa M; Bravo J; Szilágyi Á; Csuka D; Veszeli N; Prohászka Z; Sánchez-Corral P
    Front Immunol; 2021; 12():641656. PubMed ID: 33777036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copy number variation analysis using next-generation sequencing identifies the
    Park J; Yhim HY; Kang KP; Bae TW; Cho YG
    Hematology; 2022 Dec; 27(1):603-608. PubMed ID: 35617302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Genetic Characteristics of Atypical Hemolytic Uremic Syndrome in Children: A Chinese Cohort Study.
    Wu D; Chen J; Ling C; Chen Z; Fan J; Sun Q; Meng Q; Liu X
    Nephron; 2021; 145(4):415-427. PubMed ID: 33873197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel atypical hemolytic uremic syndrome-associated hybrid CFHR1/CFH gene encoding a fusion protein that antagonizes factor H-dependent complement regulation.
    Valoti E; Alberti M; Tortajada A; Garcia-Fernandez J; Gastoldi S; Besso L; Bresin E; Remuzzi G; Rodriguez de Cordoba S; Noris M
    J Am Soc Nephrol; 2015 Jan; 26(1):209-19. PubMed ID: 24904082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.
    Francis NJ; McNicholas B; Awan A; Waldron M; Reddan D; Sadlier D; Kavanagh D; Strain L; Marchbank KJ; Harris CL; Goodship TH
    Blood; 2012 Jan; 119(2):591-601. PubMed ID: 22058112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases.
    Blanc C; Togarsimalemath SK; Chauvet S; Le Quintrec M; Moulin B; Buchler M; Jokiranta TS; Roumenina LT; Fremeaux-Bacchi V; Dragon-Durey MA
    J Immunol; 2015 Jun; 194(11):5129-38. PubMed ID: 25917093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
    Martínez-Barricarte R; Heurich M; López-Perrote A; Tortajada A; Pinto S; López-Trascasa M; Sánchez-Corral P; Morgan BP; Llorca O; Harris CL; Rodríguez de Córdoba S
    Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The major autoantibody epitope on factor H in atypical hemolytic uremic syndrome is structurally different from its homologous site in factor H-related protein 1, supporting a novel model for induction of autoimmunity in this disease.
    Bhattacharjee A; Reuter S; Trojnár E; Kolodziejczyk R; Seeberger H; Hyvärinen S; Uzonyi B; Szilágyi Á; Prohászka Z; Goldman A; Józsi M; Jokiranta TS
    J Biol Chem; 2015 Apr; 290(15):9500-10. PubMed ID: 25659429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
    Moore I; Strain L; Pappworth I; Kavanagh D; Barlow PN; Herbert AP; Schmidt CQ; Staniforth SJ; Holmes LV; Ward R; Morgan L; Goodship TH; Marchbank KJ
    Blood; 2010 Jan; 115(2):379-87. PubMed ID: 19861685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
    Józsi M; Licht C; Strobel S; Zipfel SL; Richter H; Heinen S; Zipfel PF; Skerka C
    Blood; 2008 Feb; 111(3):1512-4. PubMed ID: 18006700
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.